Literature DB >> 28813319

Reward functioning in posttraumatic stress and substance use disorders.

Anka A Vujanovic1, Margaret C Wardle2, Lia J Smith3, Erin C Berenz4.   

Abstract

Posttraumatic stress disorder (PTSD) and substance use disorders (SUD) are complex psychiatric conditions that commonly co-occur. Research on PTSD-SUD comorbidity has increasingly focused upon better understanding biopsychosocial factors that may contribute to their co-occurring etiology, maintenance, and treatment. Anhedonia, defined as a lack of pleasure from or interest in rewards, stems from deficits in reward functioning and is associated with specific neurocircuitries. Few studies have investigated the role of reward functioning in PTSD-SUD. The overarching aims of this review are to: define the major facets of reward functioning, summarize the research on reward functioning-PTSD and reward functioning-SUD, review the literature on associations between reward functioning and PTSD-SUD comorbidity, and discuss clinical implications and future directions.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2016        PMID: 28813319     DOI: 10.1016/j.copsyc.2016.11.004

Source DB:  PubMed          Journal:  Curr Opin Psychol        ISSN: 2352-250X


  11 in total

1.  An IL-6 receptor antagonist attenuates postpartum anhedonia, but has no effect on anhedonia precipitated by subchronic stress in female rats.

Authors:  Julie Gomez; Nicole A Haas; Jaclyn M Schwarz
Journal:  Psychopharmacology (Berl)       Date:  2019-03-04       Impact factor: 4.530

2.  Temporal precedence of self-regulation over depression and alcohol problems: Support for a model of self-regulatory failure.

Authors:  Samuel F Acuff; Kathryn E Soltis; Ashley A Dennhardt; Brian Borsari; Matthew P Martens; Katie Witkiewitz; James G Murphy
Journal:  Psychol Addict Behav       Date:  2019-08-26

3.  Structural connectivity and risk for anhedonia after trauma: A prospective study and replication.

Authors:  Negar Fani; Vasiliki Michopoulos; Sanne J H van Rooij; Cherita Clendinen; Raven A Hardy; Tanja Jovanovic; Barbara O Rothbaum; Kerry J Ressler; Jennifer S Stevens
Journal:  J Psychiatr Res       Date:  2019-05-14       Impact factor: 4.791

4.  Access to environmental reward mediates the relation between posttraumatic stress symptoms and alcohol problems and craving.

Authors:  Samuel F Acuff; Matthew T Luciano; Kathryn E Soltis; Keanan J Joyner; Meghan McDevitt-Murphy; James G Murphy
Journal:  Exp Clin Psychopharmacol       Date:  2018-01-22       Impact factor: 3.157

5.  Depressive symptoms as predictors of alcohol problem domains and reinforcement among heavy drinking college students.

Authors:  Samuel F Acuff; Kathryn E Soltis; Matthew T Luciano; Lidia Z Meshesha; Paola Pedrelli; Ashley A Dennhardt; James G Murphy
Journal:  Psychol Addict Behav       Date:  2018-10-04

6.  The Role of Affect in Psychosocial Treatments for Substance Use Disorders.

Authors:  Julia E Swan; Victoria R Votaw; Elena R Stein; Katie Witkiewitz
Journal:  Curr Addict Rep       Date:  2020-06-01

7.  Does Anhedonia Presage Increased Risk of Posttraumatic Stress Disorder? : Adolescent Anhedonia and Posttraumatic Disorders.

Authors:  Victoria B Risbrough; Laura M Glynn; Elysia P Davis; Curt A Sandman; Andre Obenaus; Hal S Stern; David B Keator; Michael A Yassa; Tallie Z Baram; Dewleen G Baker
Journal:  Curr Top Behav Neurosci       Date:  2018

8.  Experimental manipulations of behavioral economic demand for addictive commodities: a meta-analysis.

Authors:  Samuel F Acuff; Michael Amlung; Ashley A Dennhardt; James MacKillop; James G Murphy
Journal:  Addiction       Date:  2019-12-19       Impact factor: 6.526

9.  Affective dynamics among veterans: Associations with distress tolerance and posttraumatic stress symptoms.

Authors:  Jeffrey S Simons; Raluca M Simons; Kevin J Grimm; Jessica A Keith; Scott F Stoltenberg
Journal:  Emotion       Date:  2020-03-19

10.  [Comorbidity of posttraumatic stress disorder and addiction from a biopsychosocial perspective].

Authors:  Hans-Peter Kapfhammer
Journal:  Neuropsychiatr       Date:  2021-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.